e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Obstructive sleep apnoea as a comorbidity
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microparticles from OSA patients induce hyper-reactivity through up-regulation of pro-inflammatory proteins
S. Tual-Chalot, K. Fatoumata, P. Priou, W. Trzepizur, C. Contreras, D. Prieto, M. C. Martinez, F. Gagnadoux, R. Andriantsitohaina (Angers, France; Madrid, Spain)
Source:
Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Session:
Obstructive sleep apnoea as a comorbidity
Session type:
Poster Discussion
Number:
3469
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Tual-Chalot, K. Fatoumata, P. Priou, W. Trzepizur, C. Contreras, D. Prieto, M. C. Martinez, F. Gagnadoux, R. Andriantsitohaina (Angers, France; Madrid, Spain). Microparticles from OSA patients induce hyper-reactivity through up-regulation of pro-inflammatory proteins. Eur Respir J 2011; 38: Suppl. 55, 3469
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006
Extracellular Hsp70 modulates inflammatory response in PBEC cells from COPD patients
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Involvement of nitric oxide, proinflammatory cytokines and effector cells in the inflammatory process in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005
The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Proinflammatory cytokines in induced sputum and COPD phenotype
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Airway fibroblasts phenotype markers after pro-inflammatory cytokines challenge
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Aerobic training inhibits leukocytes production of oxidants, pro-inflammatory and pro-fibrotic factors reducing asthmatic phenotype
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
Pro-inflammatory cytokines stimulate airway mucus secretion in a rat model of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 520s
Year: 2001
The pro-resoliving lipid mediator lipoxin A4 inversely correlates with proinflammatory chemokines and identifies a subgroup of asthma patients with disease progression
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Source: Eur Respir J 2003; 22: 290-297
Year: 2003
Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis
Source: Eur Respir J 2003; 21: 925-931
Year: 2003
EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
Mast cell tryptase induce alarmin release and secretion of pro-inflammatory cytokines from bronchial epithelial cells
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Interleukin-17 cytokine signalling in patients with asthma
Source: Eur Respir J 2014; 44: 1319-1331
Year: 2014
RAGE-dependent VCAM-1 expression in the pulmonary endothelium mediates IL-33 induced asthma pathogenesis
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017
The levels of proinflammatory cytokines in patients with dust-induced lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 536s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept